Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
March-2018 Volume 17 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2018 Volume 17 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Treatment with Shuyu capsule increases 5-HT1AR level and activation of cAMP-PKA-CREB pathway in hippocampal neurons treated with serum from a rat model of depression

  • Authors:
    • Xiao‑Long Wang
    • Jie Gao
    • Xiao‑Yu Wang
    • Xiao‑Fei Mu
    • Sheng Wei
    • Ling Xue
    • Ming‑Qi Qiao
  • View Affiliations / Copyright

    Affiliations: School of Pharmacy, School of Basic Medical Sciences, Shandong University of Traditional Chinese Medicine, Jinan, Shangdong 250355, P.R. China, Institute of Traditional Chinese Medicine Basic Theory, School of Basic Medical Sciences, Shandong University of Traditional Chinese Medicine, Jinan, Shangdong 250355, P.R. China, Laboratory Animal Center, Shandong University of Traditional Chinese Medicine, Jinan, Shangdong 250355, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3575-3582
    |
    Published online on: December 22, 2017
       https://doi.org/10.3892/mmr.2017.8339
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Depressive disorder (DD) is one of the typical affective disorders with a high morbidity, high suicide rate and high recurrence rate. Dysfunction of the 5‑hydroxytryptamine 1A receptor (5‑HT1AR) in the brain may serve an important role in the pathogenesis of DD. Currently, selective serotonin reuptake inhibitors are the first line antidepressants with 60‑70% efficacy and severe adverse effects. Previous studies have demonstrated that Chinese herbal medicines, including the Shuyu capsule (SYC), are effective antidepressants with few side effects. However, the mechanism remains unclear. In the present study, the effects of the SYC on the 5‑HT1AR level and the activation of adenylyl cyclase‑cyclic adenosine monophosphate (cAMP)‑protein kinase A (PKA)‑cAMP response element‑binding (CREB) signaling pathway that 5‑HT1AR mediates in the cells of hippocampal neurons were investigated in vitro. The SYC demonstrated an antidepressant effect similar to that of fluoxetine in a rat depression model. Treatment of hippocampal neurons with the serum of depressive rats resulted in a decrease in the 5‑HT1AR protein level and the activation of the cAMP‑PKA‑CREB signaling pathway in hippocampal neurons. Exposure to the serum of rats that received chronic mild stress plus SYC treatment led to no alterations in the 5‑HT1AR level or the activation of the cAMP‑PKA‑CREB signaling pathway compared with those of cells exposed to normal rat serum. This effect is similar to the effects of 5‑HT1AR antagonist WAY‑100635. In addition, the 5‑HT1A agonist 8‑hydroxy‑(dipropylamino) tetralin did not antagonize the effects of the SYC. Furthermore, the SYC exhibited an increased effect compared with fluoxetine on 5‑HT1AR levels and CREB activation. The present study suggested that the SYC functions by increasing 5‑HT1AR protein levels and the activation of the 5‑HT1AR‑mediated cAMP‑PKA‑CREB signaling pathway in hippocampal neurons.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Isometsä E: Suicidal behaviour in mood disorders-who, when and why? Can J Psychiatry. 59:120–130. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Song L, Che W, Min-Wei W, Murakami Y and Matsumoto K: Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacol Biochem Behav. 83:186–193. 2006. View Article : Google Scholar : PubMed/NCBI

3 

Delgado PL: Depression: The case for a monoamine deficiency. J Clin Psychiatry. 61 Suppl 6:S7–S11. 2000.

4 

Dording CM, Mischoulon D, Petersen TJ, Kornbluh R, Gordon J, Nierenberg AA, Rosenbaum JE and Fava M: The pharmacologic management of SSRI-induced side effects: A survey of psychiatrists. Ann Clin Psychiatry. 14:143–147. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Fitzgerald KT and Bronstein AC: Selective serotonin reuptake inhibitor exposure. Top Companion Anim Med. 28:13–17. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Butler L and Pilkington K: Chinese herbal medicine and depression: The research evidence. Evid Based Complement Alternat Med. 2013:7397162013. View Article : Google Scholar : PubMed/NCBI

7 

Qin F, Wu XA, Tang Y, Huang Q, Zhang ZJ and Yuan JH: Meta-analysis of randomized controlled trials to assess the effectiveness and safety of free and easy wanderer plus, a polyherbal preparation for depressive disorders. J Psychiatr Res. 45:1518–1524. 2011. View Article : Google Scholar : PubMed/NCBI

8 

Zhang Y, Han M, Liu Z, Wang J, He Q and Liu J: Chinese herbal formula xiao yao san for treatment of depression: A systematic review of randomized controlled trials. Evid Based Complement Alternat Med. 2012:9316362012.PubMed/NCBI

9 

Lee B, Yun HY, Shim I, Lee H and Hahm DH: Bupleurum falcatum prevents depression and anxiety-like behaviors in rats exposed to repeated restraint stress. J Microbiol Biotechnol. 22:422–430. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Qiu F, Zhong X, Mao Q and Huang Z: The antidepressant-like effects of paeoniflorin in mouse models. Exp Ther Med. 5:1113–1116. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Dhingra D and Sharma A: Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests. Prog Neuropsychopharmacol Biol Psychiatry. 30:449–454. 2006. View Article : Google Scholar : PubMed/NCBI

12 

Sarris J, Panossian A, Schweitzer I, Stough C and Scholey A: Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 21:841–460. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Xu K, Li Z and Gao J: Effect of Shuyu capsule on liver-qi stagnation rat model of depressive disorder based on the analysis of gene expression microarray technique. Chin Pharmocol Bulletin. 30:437–438. 2014.(In Chinese).

14 

Gordon JA and Hen R: The serotonergic system and anxiety. Neuromolecular Med. 5:27–40. 2004. View Article : Google Scholar : PubMed/NCBI

15 

Robinson DS, Rickels K, Feighner J, Fabre LF Jr, Gammans RE, Shrotriya RC, Alms DR, Andary JJ and Messina ME: Clinical effects of the 5-HT1A partial agonists in depression: A composite analysis of buspirone in the treatment of depression. J Clin Psychopharmacol. 10:67S–76S. 1990. View Article : Google Scholar : PubMed/NCBI

16 

Wong DT, Bymaster FP and Engleman EA: Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci. 57:411–441. 1995. View Article : Google Scholar : PubMed/NCBI

17 

Riad M, Zimmer L, Rbah L, Watkins KC, Hamon M and Descarries L: Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. J Neurosci. 24:5420–4526. 2004. View Article : Google Scholar : PubMed/NCBI

18 

Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ and Mathis C: Serotonin-1A receptor imaging in recurrent depression: Replication and literature review. Nucl Med Biol. 34:865–877. 2007. View Article : Google Scholar : PubMed/NCBI

19 

Savitz J, Lucki I and Drevets WC: 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol. 88:17–31. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Birnbaumer L: Expansion of signal transduction by G proteins. The second 15 years or so: From 3 to 16 alpha subunits plus betagamma dimers. Biochim Biophys Acta. 1768:772–793. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Pucadyil TJ, Kalipatnapu S and Chattopadhyay A: The serotonin1A receptor: A representative member of the serotonin receptor family. Cell Mol Neurobiol. 25:553–580. 2005. View Article : Google Scholar : PubMed/NCBI

22 

Ohno Y: New insight into the therapeutic role of 5-HT1A receptors in central nervous system disorders. Cent Nerv Syst Agents Med Chem. 10:148–157. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Kim MH and Leem YH: Chronic exercise improves repeated restraint stress-induced anxiety and depression through 5HT1A receptor and cAMP signaling in hippocampus. J Exerc Nutrition Biochem. 18:97–104. 2014. View Article : Google Scholar : PubMed/NCBI

24 

Wang C, Guo J and Guo R: Effect of XingPiJieYu decoction on spatial learning and memory and cAMP-PKA-CREB-BDNF pathway in rat model of depression through chronic unpredictable stress. BMC Complement Altern Med. 17:732017. View Article : Google Scholar : PubMed/NCBI

25 

Thome J, Henn FA and Duman RS: Cyclic AMP response element-binding protein and depression. Expert Rev Neurother. 2:347–354. 2002. View Article : Google Scholar : PubMed/NCBI

26 

Wang FR, Qiao MQ, Xue L and Wei S: Possible involvement of µ opioid receptor in the antidepressant-like effect of shuyu formula in restraint stress-induced depression-like rats. Evid Based Complement Alternat Med. 2015:4524122015.PubMed/NCBI

27 

Willner P, Towell A, Sampson D, Sophokleous S and Muscat R: Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl). 93:358–364. 1987. View Article : Google Scholar : PubMed/NCBI

28 

Nunez J: Primary culture of hippocampal neurons from P0 newborn rats. J Vis Exp. 19:pii: 8952008.

29 

Gaillard R, Gourion D and Llorca PM: Anhedonia in depression. Encephale. 39:296–305. 2013. View Article : Google Scholar : PubMed/NCBI

30 

Overstreet DH: Modeling depression in animal models. Methods Mol Biol. 829:125–144. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Willner P: Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation. Psychopharmacology (Berl). 134:319–329. 1997. View Article : Google Scholar : PubMed/NCBI

32 

Muscat R and Willner P: Suppression of sucrose drinking by chronic mild unpredictable stress: A methodological analysis. Neurosci Biobehav Rev. 16:507–517. 1992. View Article : Google Scholar : PubMed/NCBI

33 

Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA, Almeida OF and Sousa N: The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry. 14:764–773. 2009.39. View Article : Google Scholar : PubMed/NCBI

34 

Leach G, Adidharma W and Yan L: Depression-like responses induced by daytime light deficiency in the diurnal grass rat (Arvicanthis niloticus). PLoS One. 8:e571152013. View Article : Google Scholar : PubMed/NCBI

35 

Yu J, Liu Q, Wang YQ, Wang J, Li XY, Cao XD and Wu GC: Electroacupuncture combined with clomipramine enhances antidepressant effect in rodents. Neurosci Lett. 421:5–9. 2007. View Article : Google Scholar : PubMed/NCBI

36 

Wu X, Alberico SL, Moges H, De Taboada L, Tedford CE and Anders JJ: Pulsed light irradiation improves behavioral outcome in a rat model of chronic mild stress. Lasers Surg Med. 44:227–232. 2012. View Article : Google Scholar : PubMed/NCBI

37 

Iwama H, Amagaya S and Ogihara Y: Effect of shosaikoto, a Japanese and Chinese traditional herbal medicinal mixture, on the mitogenic activity of lipopolysaccharide: A new pharmacological testing method. J Ethnopharmacol. 21:45–53. 1987. View Article : Google Scholar : PubMed/NCBI

38 

Li F, Zhang YB, Wei X, Song CH, Qiao MQ and Zhang HY: Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MSn. Mol Med Rep. 13:4191–4204. 2016. View Article : Google Scholar : PubMed/NCBI

39 

Stahl S: 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? Psychopharmacol Bull. 30:39–43. 1994.PubMed/NCBI

40 

Larsson LG, Stenfors C and Ross SB: Differential regional antagonism of 8-OH-DPAT-induced decrease in serotonin synthesis by two 5-HT1A receptor antagonists. Eur J Pharmacol. 346:209–215. 1998. View Article : Google Scholar : PubMed/NCBI

41 

De Vry J, Schreiber R, Melon C, Dalmus M and Jentzsch KR: 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur Neuropsychopharmacol. 14:487–495. 2004. View Article : Google Scholar : PubMed/NCBI

42 

Shishkina GT, Kalinina TS and Dygalo NN: Effects of swim stress and fluoxetine on 5-HT1A receptor gene expression and monoamine metabolism in the rat brain regions. Cell Mol Neurobiol. 32:787–794. 2012. View Article : Google Scholar : PubMed/NCBI

43 

Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS and Young LT: G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: Effects of diagnosis, suicide, and treatment at the time of death. J Neurochem. 73:1121–1126. 1999. View Article : Google Scholar : PubMed/NCBI

44 

Shelton RC, Mainer DH and Sulser F: cAMP-dependent protein kinase activity in major depression. Am J Psychiatry. 153:1037–10342. 1996. View Article : Google Scholar : PubMed/NCBI

45 

Li YC, Wang FM, Pan Y, Qiang LQ, Cheng G, Zhang WY and Kong LD: Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog Neuropsychopharmacol Biol Psychiatry. 33:435–449. 2009. View Article : Google Scholar : PubMed/NCBI

46 

Hsiung SC, Tin A, Tamir H, Franke TF and Liu KP: Inhibition of 5-HT1A receptor-dependent cell survival by cAMP/protein kinase A: Role of protein phosphatase 2A and Bax. J Neurosci Res. 86:2326–2338. 2008. View Article : Google Scholar : PubMed/NCBI

47 

Duman RS, Malberg J, Nakagawa S and D'Sa C: Neuronal plasticity and survival in mood disorders. Biol Psychiatry. 48:732–739. 2000. View Article : Google Scholar : PubMed/NCBI

48 

Shaywitz AJ and Greenberg ME: CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 68:821–861. 1999. View Article : Google Scholar : PubMed/NCBI

49 

Tiraboschi E, Tardito D, Kasahara J, Moraschi S, Pruneri P, Gennarelli M, Racagni G and Popoli M: Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology. 29:1831–1840. 2004. View Article : Google Scholar : PubMed/NCBI

50 

Duman CH, Schlesinger L, Kodama M, Russell DS and Duman RS: A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry. 61:661–670. 2007. View Article : Google Scholar : PubMed/NCBI

51 

Seth P, Gajendiran M and Ganguly DK: Desensitization of spinal 5-HT1A receptors to 8-OH-DPAT: An in vivo spinal reflex study. Neuroreport. 8:2489–2493. 1997. View Article : Google Scholar : PubMed/NCBI

52 

Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, et al: Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res. 73:337–353. 1996. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang XL, Gao J, Wang XY, Mu XF, Wei S, Xue L and Qiao MQ: Treatment with Shuyu capsule increases 5-HT1AR level and activation of cAMP-PKA-CREB pathway in hippocampal neurons treated with serum from a rat model of depression. Mol Med Rep 17: 3575-3582, 2018.
APA
Wang, X., Gao, J., Wang, X., Mu, X., Wei, S., Xue, L., & Qiao, M. (2018). Treatment with Shuyu capsule increases 5-HT1AR level and activation of cAMP-PKA-CREB pathway in hippocampal neurons treated with serum from a rat model of depression. Molecular Medicine Reports, 17, 3575-3582. https://doi.org/10.3892/mmr.2017.8339
MLA
Wang, X., Gao, J., Wang, X., Mu, X., Wei, S., Xue, L., Qiao, M."Treatment with Shuyu capsule increases 5-HT1AR level and activation of cAMP-PKA-CREB pathway in hippocampal neurons treated with serum from a rat model of depression". Molecular Medicine Reports 17.3 (2018): 3575-3582.
Chicago
Wang, X., Gao, J., Wang, X., Mu, X., Wei, S., Xue, L., Qiao, M."Treatment with Shuyu capsule increases 5-HT1AR level and activation of cAMP-PKA-CREB pathway in hippocampal neurons treated with serum from a rat model of depression". Molecular Medicine Reports 17, no. 3 (2018): 3575-3582. https://doi.org/10.3892/mmr.2017.8339
Copy and paste a formatted citation
x
Spandidos Publications style
Wang XL, Gao J, Wang XY, Mu XF, Wei S, Xue L and Qiao MQ: Treatment with Shuyu capsule increases 5-HT1AR level and activation of cAMP-PKA-CREB pathway in hippocampal neurons treated with serum from a rat model of depression. Mol Med Rep 17: 3575-3582, 2018.
APA
Wang, X., Gao, J., Wang, X., Mu, X., Wei, S., Xue, L., & Qiao, M. (2018). Treatment with Shuyu capsule increases 5-HT1AR level and activation of cAMP-PKA-CREB pathway in hippocampal neurons treated with serum from a rat model of depression. Molecular Medicine Reports, 17, 3575-3582. https://doi.org/10.3892/mmr.2017.8339
MLA
Wang, X., Gao, J., Wang, X., Mu, X., Wei, S., Xue, L., Qiao, M."Treatment with Shuyu capsule increases 5-HT1AR level and activation of cAMP-PKA-CREB pathway in hippocampal neurons treated with serum from a rat model of depression". Molecular Medicine Reports 17.3 (2018): 3575-3582.
Chicago
Wang, X., Gao, J., Wang, X., Mu, X., Wei, S., Xue, L., Qiao, M."Treatment with Shuyu capsule increases 5-HT1AR level and activation of cAMP-PKA-CREB pathway in hippocampal neurons treated with serum from a rat model of depression". Molecular Medicine Reports 17, no. 3 (2018): 3575-3582. https://doi.org/10.3892/mmr.2017.8339
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team